carmustine has been researched along with Blindness in 1 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The syndrome of retinal vascular occlusion, optic neuropathy, and myelopathy is associated with the high-dose chemotherapeutic agents carmustine and cisplatin." | 7.70 | Bilateral blindness and lumbosacral myelopathy associated with high-dose carmustine and cisplatin therapy. ( Arnold, AC; Glasgow, BJ; Vinters, HV; Wang, MY, 2000) |
| "The syndrome of retinal vascular occlusion, optic neuropathy, and myelopathy is associated with the high-dose chemotherapeutic agents carmustine and cisplatin." | 3.70 | Bilateral blindness and lumbosacral myelopathy associated with high-dose carmustine and cisplatin therapy. ( Arnold, AC; Glasgow, BJ; Vinters, HV; Wang, MY, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, MY | 1 |
| Arnold, AC | 1 |
| Vinters, HV | 1 |
| Glasgow, BJ | 1 |
1 other study available for carmustine and Blindness
| Article | Year |
|---|---|
Bilateral blindness and lumbosacral myelopathy associated with high-dose carmustine and cisplatin therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blindness; Breast Neoplasms; Carcinoma, Ductal, Brea | 2000 |